Edition:
India

Morepen Laboratories Ltd (MORL.NS)

MORL.NS on National Stock Exchange of India

20.20INR
3:56pm IST
Change (% chg)

Rs0.85 (+4.39%)
Prev Close
Rs19.35
Open
Rs19.90
Day's High
Rs22.20
Day's Low
Rs19.40
Volume
2,122,883
Avg. Vol
665,418
52-wk High
Rs37.10
52-wk Low
Rs14.55

Latest Key Developments (Source: Significant Developments)

Morepen Laboratories Says Twin US FDA Approvals For Bulk Drugs Facilities
Monday, 30 Jul 2018 

July 30 (Reuters) - Morepen Laboratories Ltd ::SAYS TWIN USFDA APPROVALS FOR MOREPEN LABS BULK DRUGS (API) FACILITIES.BADDI FACILITY GETS US FDA NOD FOR BULK DRUG "ATORVASTATIN" AND MASULKHANA FACILITY FOR "MONTELUKAST".  Full Article

India's Morepen Laboratories Dec Qtr Profit Rises
Monday, 22 Jan 2018 

Jan 22 (Reuters) - Morepen Laboratories Ltd ::DEC QUARTER REVENUE FROM OPERATIONS 1.42 BILLION RUPEES VERSUS 1.39 BILLION RUPEES YEAR AGO.DEC QUARTER NET PROFIT 96.7 MILLION RUPEES VERSUS PROFIT 46.8 MILLION RUPEES YEAR AGO.  Full Article

India's Morepen Laboratories Gets U.S. FDA Nod For Bulk Drug Montelukast Sodium
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Morepen Laboratories Ltd ::GETS U.S. FDA CLEARANCE FOR ITS BULK DRUG MONTELUKAST SODIUM.  Full Article

India's Morepen Labs Sept-qtr profit rises
Friday, 10 Nov 2017 

Nov 10 (Reuters) - Morepen Laboratories Ltd ::Sept quarter net profit 103.8 million rupees versus 83.4 million rupees year ago.Sept quarter revenue from operations 1.38 billion rupees versus 1.43 billion rupees year ago.  Full Article

India's Morepen Laboratories June-qtr profit falls
Monday, 11 Sep 2017 

Sept 11 (Reuters) - Morepen Laboratories Ltd :June quarter net profit 19.6 million rupees versus profit 29.8 million rupees year ago.June quarter total revenue 1.24 billion rupees versus 1.21 billion rupees year ago.  Full Article